Notably, the upregulated PTX3 levels in bronchoalveolar lavage fluid also serve as a biomarker for lung cancer, particularly in small cell lung cancer (SCLC) and in cases with obstructive pneumonia (85). This evidence concerns the gene PTX3 and lung carcinoma.